Jeffrey R. Marks, Ph.D.
Recent Publications

Hoyo C,Grubber J,Demark-Wahnefried W,Lobaugh B,Jeffreys AS,Grambow SC,Marks JR,Keku TO,Walther PJ,Schildkraut JM. Predictors of variation in serum IGF1 and IGFBP3 levels in healthy African American and white men.,7/1/2009, (711-6) - Journal of the National Medical Association Abstract [More ...] Westmoreland TJ,Wickramasekara SM,Guo AY,Selim AL,Winsor TS,Greenleaf AL,Blackwell KL,Olson JA Jr,Marks JR,Bennett CB. Comparative genome-wide screening identifies a conserved doxorubicin repair network that is diploid specific in Saccharomyces cerevisiae.,6/8/2009, (e5830) - PloS one Abstract [More ...] Hoyo C,Schildkraut JM,Murphy SK,Chow WH,Vaughan TL,Risch H,Marks JR,Jirtle RL,Calingeart B,Mayne S,Fraumeni J Jr,Gammon MD. IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas.,6/2/2009, (-) - International journal of cancer. Journal international du cancer Abstract [More ...] Jesneck JL,Mukherjee S,Yurkovetsky Z,Clyde M,Marks JR,Lokshin AE,Lo JY. Do serum biomarkers really measure breast cancer?,5/28/2009, (164) - BMC cancer Abstract [More ...] Levina V,Nolen BM,Marrangoni AM,Cheng P,Marks JR,Szczepanski MJ,Szajnik ME,Gorelik E,Lokshin AE. Role of Eotaxin-1 Signaling in Ovarian Cancer.,4/15/2009, (2647-2656) - Clinical cancer research : an official journal of the American Association for Cancer Research Abstract [More ...] Berchuck A,Iversen ES,Luo J,Clarke JP,Horne H,Levine DA,Boyd J,Alonso MA,Secord AA,Bernardini MQ,Barnett JC,Boren T,Murphy SK,Dressman HK,Marks JR,Lancaster JM. Microarray Analysis of Early Stage Serous Ovarian Cancers Shows Profiles Predictive of Favorable Outcome.,3/24/2009, (-) - Clinical cancer research : an official journal of the American Association for Cancer Research Abstract [More ...] Schildkraut JM,Goode EL,Clyde MA,Iversen ES,Moorman PG,Berchuck A,Marks JR,Lissowska J,Brinton L,Peplonska B,Cunningham JM,Vierkant RA,Rider DN,Chenevix-Trench G,Webb PM,Beesley J,Chen X,Phelan C,Sutphen R,Sellers TA,Pearce L,Wu AH,Van Den Berg D,Conti D,Elund CK,Anderson R,Goodman MT,Lurie G,Carney ME,Thompson PJ,Gayther SA,Ramus SJ,Jacobs I,Krüger Kjaer S,Hogdall E,Blaakaer J,Hogdall C,Easton DF,Song H,Pharoah PD,Whittemore AS,McGuire V,Quaye L,Anton-Culver H,Ziogas A,Terry KL,Cramer DW,Hankinson SE,Tworoger SS,Calingaert B,Chanock S,Sherman M,Garcia-Closas M. Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer.,3/15/2009, (2349-57) - Cancer research Abstract [More ...] Tebbit CL,Zhai J,Untch BR,Ellis MJ,Dressman HK,Bentley RC,Baker JA,Marcom PK,Nevins JR,Marks JR,Olson JA Jr. Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: a study to determine feasibility and reproducibility in the context of clinical care.,2/18/2009, (-) - Breast cancer research and treatment Abstract [More ...] Horne HN,Lee PS,Murphy SK,Alonso MA,Olson JA Jr,Marks JR. Inactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapy.,2/1/2009, (199-209) - Molecular cancer research : MCR Abstract [More ...] Schildkraut JM,Moorman PG,Bland AE,Halabi S,Calingaert B,Whitaker R,Lee PS,Elkins-Williams T,Bentley RC,Marks JR,Berchuck A. Cyclin e overexpression in epithelial ovarian cancer characterizes an etiologic subgroup.,3/1/2008, (585-93) - Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology Abstract [More ...]

---

NOTE: For more publications on this researcher, please visit Pubmed - A service of the National Library of Medicine and the National Institutes of Health.